NOT-CA-03-039: NOVEL TECHNOLOGIES FOR NONINVASIVE DETECTION, DIAGNOSIS AND TREATMENT OF CANCER

Department of Health
and Human Services (HHS)

NIH... Turning Discovery Into Health^®


NOVEL TECHNOLOGIES FOR NONINVASIVE DETECTION, DIAGNOSIS AND TREATMENT 
OF CANCER

RELEASE DATE:  October 20, 2003

NOTICE:  NOT-CA-03-039

National Cancer Institute (NCI)
 (http://www.nci.nih.gov)

The Unconventional Innovations Program (UIP) of the National Cancer 
Institute (NCI) is seeking revolutionary technologies for cancer 
research.  The UIP is soliciting proposals for the development of 
multifunctional technology platforms to support minimally intrusive 
approaches that integrate: a) sensing of the fundamental signatures of 
precancers, or early, metastatic or recurring cancers in the living 
body; b) transmission of signature information to an external monitor; 
c) controlled, specific, treatment; d) monitoring of the effects of 
treatment.  The UIP particularly seeks technology platforms that 
integrate novel approaches to signature recognition, signal generation, 
signal amplification, signal transmission, intervention delivery, 
intervention feedback, and data interpretation.  Proposals are 
encouraged from investigators from a variety of disciplines including, 
but not limited to, biomedical research, chemistry, physics, 
engineering, and computational sciences. Proposals from 
multidisciplinary teams are particularly encouraged.  The detailed 
Broad Agency Announcement is available on the web site of the Research 
Contracts Branch, NCI at: 
http://rcb.cancer.gov/rcb-internet/appl/rfp/published_rfps.jsp 
with instructions for submission of proposal and evaluation criteria.  
Investigators are encouraged to visit the UIP websites;  
http://otir.cancer.gov/tech/uip.html  for a 
program overview, and http://otir.cancer.gov/tech/uip_awards.html 
for abstracts of currently funded UIP contractors.

INQUIRIES

For Further information, contact:

Annmarie L. Keane  
Contract Specialist  
National Cancer Institute  
Treatment, Biology, and Science Section, RCB  
Executive Plaza South  
6120 Executive Blvd., MSC 7193  
Suite 6056 
Bethesda, MD 20892  
Telephone:  301-435-3814  
Fax:  301-402-6699  
Email:  [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices